These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28403214)

  • 81. The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance.
    Dianat-Moghadam H; Azizi M; Eslami-S Z; Cortés-Hernández LE; Heidarifard M; Nouri M; Alix-Panabières C
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260071
    [TBL] [Abstract][Full Text] [Related]  

  • 82. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset.
    Agnoletto C; Corrà F; Minotti L; Baldassari F; Crudele F; Cook WJJ; Di Leva G; d'Adamo AP; Gasparini P; Volinia S
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30959764
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine.
    Tellez-Gabriel M; Cochonneau D; Cadé M; Jubellin C; Heymann MF; Heymann D
    Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30586936
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
    Nevel KS; Wilcox JA; Robell LJ; Umemura Y
    Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis.
    Kitz J; Lowes LE; Goodale D; Allan AL
    Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29710776
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Technologies for detection of circulating tumor cells: facts and vision.
    Alix-Panabières C; Pantel K
    Lab Chip; 2014 Jan; 14(1):57-62. PubMed ID: 24145967
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
    Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
    Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® system.
    Balasubramanian P; Kinders RJ; Kummar S; Gupta V; Hasegawa D; Menachery A; Lawrence SM; Wang L; Ferry-Galow K; Davis D; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2017; 12(4):e0175414. PubMed ID: 28403214
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 91. ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood.
    Gupta V; Jafferji I; Garza M; Melnikova VO; Hasegawa DK; Pethig R; Davis DW
    Biomicrofluidics; 2012 Jun; 6(2):24133. PubMed ID: 23805171
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.
    O'Shannessy DJ; Davis DW; Anderes K; Somers EB
    Biomark Insights; 2016; 11():7-18. PubMed ID: 26848256
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
    Bobek V; Gurlich R; Eliasova P; Kolostova K
    World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Challenges of Detecting Circulating Tumor Cells in Sarcoma.
    Tellez-Gabriel M; Brown HK; Young R; Heymann MF; Heymann D
    Front Oncol; 2016; 6():202. PubMed ID: 27656422
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.
    Sundaresan TK; Sequist LV; Heymach JV; Riely GJ; Jänne PA; Koch WH; Sullivan JP; Fox DB; Maher R; Muzikansky A; Webb A; Tran HT; Giri U; Fleisher M; Yu HA; Wei W; Johnson BE; Barber TA; Walsh JR; Engelman JA; Stott SL; Kapur R; Maheswaran S; Toner M; Haber DA
    Clin Cancer Res; 2016 Mar; 22(5):1103-10. PubMed ID: 26446944
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.